Literature DB >> 23998400

Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients.

Michael Kent1, Rodney Landreneau, Sumithra Mandrekar, Shauna Hillman, Francis Nichols, David Jones, Sandra Starnes, Angelina Tan, Joe Putnam, Brian Meyers, Benedict Daly, Hiran C Fernando.   

Abstract

BACKGROUND: Patients with early-stage lung cancer and limited pulmonary reserve may not be appropriate candidates for lobectomy. In these situations, sublobar resection (wedge or segmentectomy) is generally performed. Many physicians believe that segmentectomy is superior because it allows for an improved parenchymal margin and nodal sampling.
METHODS: We performed an analysis using operative and pathology reports collected as part of planned data collection for American College of Surgeons Surgical Oncology Group (ACOSG) Z4032. This was a prospective trial in which patients with clinical stage I lung cancer and limited pulmonary function were randomized to sublobar resection with or without brachytherapy. The operative approach (video-assisted thoracic surgery [VATS] vs thoracotomy), extent of resection, and degree of lymph node evaluation were at the discretion of the individual surgeon. The primary aim of this analysis was to compare the parenchymal margin achieved between segmentectomy and wedge resection. Secondary aims included the extent of nodal staging and whether the operative approach (VATS vs open) had an effect on margin status and nodal evaluation.
RESULTS: Among 210 patients, 135 (64%) underwent a VATS approach and 75 (36%) a thoracotomy. A segmentectomy was performed in 57 patients (27%) and a wedge resection in 153 patients (73%). There were no significant differences in the degree of nodal upstaging, stations sampled, or parenchymal margin obtained between VATS and thoracotomy. However, significant differences were observed between patients who underwent a segmentectomy and those who underwent a wedge resection with regard to parenchymal margin (1.5 cm vs 0.8 cm, p = 0.0001), nodal upstaging (9% vs 1%, p = 0.006), and nodal stations sampled (3 vs 1, p < 0.0001) . Notably, 41% of patients treated by wedge resection had no nodes sampled at the time of operation compared with 2% of those who underwent segmentectomy (p < 0.0001).
CONCLUSIONS: In ACOSG Z4032, wedge resection, regardless of the approach, was associated with a smaller parenchymal margin and a lower yield of lymph nodes and rate of nodal upstaging when compared with segmentectomy.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  10

Mesh:

Year:  2013        PMID: 23998400     DOI: 10.1016/j.athoracsur.2013.05.104

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  30 in total

1.  The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Authors:  Morgan L Cox; Chi-Fu Jeffrey Yang; Paul J Speicher; Kevin L Anderson; Zachary W Fitch; Lin Gu; Robert Patrick Davis; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; David H Harpole; Mark F Berry
Journal:  J Thorac Oncol       Date:  2017-01-08       Impact factor: 15.609

2.  A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).

Authors:  Michael S Kent; Sumithra J Mandrekar; Rodney Landreneau; Francis Nichols; Nathan R Foster; Thomas A DiPetrillo; Bryan Meyers; Dwight E Heron; David R Jones; Angelina D Tan; Sandra Starnes; Joe B Putnam; Hiran C Fernando
Journal:  Ann Thorac Surg       Date:  2016-04-19       Impact factor: 4.330

3.  Oncological outcomes of sublobar resection for clinical-stage IA high-risk non-small cell lung cancer patients with a radiologically solid appearance on computed tomography.

Authors:  Aritoshi Hattori; Kazuya Takamochi; Takeshi Matsunaga; Shiaki Oh; Kenji Suzuki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-01

Review 4.  Thoracoscopic superior segmentectomy.

Authors:  Jacob R Moremen; Betty C Tong; Duykhanh P Ceppa
Journal:  Ann Cardiothorac Surg       Date:  2014-03

5.  Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (≤2 cm) Non-Small Cell Lung Cancer.

Authors:  Eric M Robinson; Ilkka K Ilonen; Kay See Tan; Andrew J Plodkowski; Matthew Bott; Manjit S Bains; Prasad S Adusumilli; Bernard J Park; Valerie W Rusch; David R Jones; James Huang
Journal:  Ann Thorac Surg       Date:  2019-08-31       Impact factor: 4.330

6.  Needlescopic-assisted uniportal video-assisted thoracoscopic pulmonary anatomical segmentectomy.

Authors:  Shun-Mao Yang; Wen-Ting Wu; Yu-Hsuan Liu; Huan-Jang Ko
Journal:  J Vis Surg       Date:  2017-09-30

Review 7.  VATS segmentectomy: past, present, and future.

Authors:  Seshiru Nakazawa; Kimihiro Shimizu; Akira Mogi; Hiroyuki Kuwano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-12-18

8.  Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?

Authors:  Alfonso Fiorelli; Francesco Paolo Caronia; Niccolò Daddi; Domenico Loizzi; Luca Ampollini; Nicoletta Ardò; Luigi Ventura; Paolo Carbognani; Rossella Potenza; Francesco Ardissone; Francesco Sollitto; Sandro Mattioli; Francesco Puma; Mario Santini; Mark Ragusa
Journal:  Surg Today       Date:  2016-04-16       Impact factor: 2.549

9.  Open, thoracoscopic and robotic segmentectomy for lung cancer.

Authors:  Chi-Fu Jeffrey Yang; Thomas A D'Amico
Journal:  Ann Cardiothorac Surg       Date:  2014-03

Review 10.  SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

Authors:  Hanbo Chen; Alexander V Louie
Journal:  Curr Treat Options Oncol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.